Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Protocol: - KPV: 200-500 mcg/day oral or subcutaneous - GHK-Cu: 1-2 mg/day subcutaneous or topical - Duration: 6-8 weeks Best for: Inflammatory arthritis, autoimmune joint conditions, multi-joint inflammation in older adults
However, both compounds individually cause: Nausea (60-80% of users at higher doses) Vomiting (20-35%) Diarrhea (25-40%) Injection site reactions (15-25%) Potential pancreatitis (rare but serious) Combining these compounds could theoretically amplify these effects, though the actual incidence and severity remain unstudied
The sale of unapproved peptides is illegal under the Medicines Act in Aotearoa
Chryssafidis P, Tsekouras AA, Macheras P
Cardiovascular risk associated with testosterone-boosting therapy: a systematic review
c) Effect size estimates for the rs10305420 association with BMI %
US$ 28.03
US$ 25.90
US$ 22.33
US$ 23.87
US$ 20.96
US$ 21.97
US$ 23.94
